Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

Can You Have a Safe Pregnancy with Myasthenia Gravis?

At a Glance

Women with myasthenia gravis can have safe, healthy pregnancies with proactive planning. The most critical steps are transitioning off harmful medications 6 to 12 months before conceiving and working closely with your healthcare team to manage potential symptom flares during and after pregnancy.

Yes, it is entirely possible to have a safe and healthy pregnancy when you have myasthenia gravis (MG). With proactive planning, a team approach involving both your neurologist and a high-risk obstetrician (such as a Maternal-Fetal Medicine specialist), most women with MG can successfully carry a baby to term and have an uncomplicated delivery [1]. However, pregnancy requires careful preparation, specifically adjusting medications before you conceive, monitoring for symptom flares, and planning for your newborn’s care immediately after birth [2].

6 to 12 Months Before Conceiving: Medication Planning

The most critical step in preparing for pregnancy is reviewing your medications with your doctor [2]. Some common MG treatments must be stopped well before you become pregnant:

  • Teratogenic drugs: Medications like mycophenolate mofetil and methotrexate can cause severe birth defects (they are teratogenic) and are contraindicated during pregnancy [3][4]. These medications require a washout period of several weeks to months before you start trying to conceive.
  • Pregnancy-compatible alternatives: Your doctor can transition you to safer medications to maintain control of your MG. Drugs such as azathioprine, cyclosporine, tacrolimus, and pyridostigmine are generally considered compatible with pregnancy and breastfeeding [5][6].
  • General preparation: Discuss starting a prenatal vitamin, as optimizing your general health is a key part of preconception planning.

During Pregnancy: Managing MG Symptoms

Having your MG symptoms stable for at least 6 to 12 months before getting pregnant is the best way to ensure stability during your pregnancy. However, hormonal and physical changes can still affect your condition:

  • Symptom flares: Between 19% and 50% of women experience an exacerbation (flare) of their MG symptoms during pregnancy [7][8]. Be alert for specific signs like worsening double vision, shortness of breath, or increased difficulty swallowing.
  • High-risk periods: Flares are most common during the first trimester and the postpartum period (the first three months after delivery) [9][10].
  • Treatment options: If a severe flare or myasthenic crisis occurs, therapies like intravenous immunoglobulin (IVIg) or plasma exchange (PLEX) can be safely used to stabilize your symptoms [11][2].

Labor & Delivery Plan: What to Expect

The uterus is made of smooth muscle, while MG only affects voluntary (skeletal) muscles. This means MG will not stop your uterus from contracting during labor.

  • Vaginal delivery: The vast majority of women with MG can have successful, uncomplicated vaginal deliveries [1].
  • Anesthesia and pain management: Regional anesthesia, such as an epidural, is generally safe and often recommended. It helps prevent muscle exhaustion and avoids the respiratory risks associated with general anesthesia. A consultation with an anesthesiologist before labor is essential.
  • Cesarean section (C-section): Your medical team will monitor you for muscle fatigue during pushing, and they maintain a lower threshold for a C-section or assisted delivery if you become too weak [1].
  • Preeclampsia management: If you develop severe preeclampsia, the standard medication used to prevent seizures is magnesium sulfate. However, this drug must be strictly avoided in MG patients because it blocks nerve signals and can trigger a myasthenic crisis [12]. Reassuringly, alternative medications like levetiracetam are just as effective at protecting your health without risking your MG [13].

Postpartum: Caring for Your Baby and Yourself

The postpartum period requires planning for both the newborn’s immediate medical needs and your own recovery.

Your Baby: Transient Neonatal Myasthenia Gravis
Because the antibodies that cause your MG can cross the placenta, your baby may temporarily experience MG symptoms after birth. This condition is called transient neonatal myasthenia gravis (TNMG).

  • Risk and monitoring: About 10% to 13% of newborns born to mothers with MG develop TNMG [2][14]. Therefore, your baby will be closely monitored in the hospital for 48 to 72 hours after birth [15].
  • Symptoms and recovery: Signs include weak crying, poor sucking or feeding, and reduced muscle tone (floppiness). TNMG is temporary and typically follows a benign course, resolving spontaneously within a few weeks as your antibodies naturally clear from the baby’s system [15][16]. Treatment for the baby, if needed, is highly effective [17].
  • Breastfeeding: Breastfeeding is generally safe and encouraged. While minimal amounts of antibodies may pass into breast milk, they do not cause TNMG, which is driven entirely by placental transfer during pregnancy.

Your Recovery
The first three months postpartum are a high-risk time for MG flares due to physical exhaustion and sleep deprivation. It is crucial to arrange for overnight help with the newborn and prioritize your rest to protect your health and avoid a crisis.

Common questions in this guide

Can I continue taking my myasthenia gravis medications while pregnant?
Some medications, like mycophenolate mofetil and methotrexate, can cause birth defects and must be stopped months before conceiving. Your doctor can safely transition you to pregnancy-compatible alternatives like azathioprine or pyridostigmine.
Will myasthenia gravis prevent me from having a vaginal delivery?
Myasthenia gravis only affects voluntary muscles, not the smooth muscles of the uterus that contract during labor. Because of this, the vast majority of women with MG can safely have successful, uncomplicated vaginal deliveries.
How is a myasthenia gravis flare treated during pregnancy?
If you experience a severe flare or myasthenic crisis while pregnant, therapies like intravenous immunoglobulin (IVIg) or plasma exchange (PLEX) can be safely used to stabilize your symptoms without harming the baby.
Why is magnesium sulfate dangerous for pregnant women with MG?
Magnesium sulfate is often used to treat severe preeclampsia in pregnant women, but it blocks nerve signals and can trigger a life-threatening myasthenic crisis in patients with MG. It must be strictly avoided, and alternative medications should be used instead.
Will my baby be born with myasthenia gravis?
Your baby will not inherit the disease, but about 10% to 13% of newborns temporarily experience transient neonatal myasthenia gravis (TNMG) because maternal antibodies cross the placenta. This condition is temporary, highly treatable, and usually resolves on its own within a few weeks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific timeline for transitioning off my current medications and confirming it is safe to start trying to conceive?
  2. 2.Which obstetricians in our network have experience managing pregnancies in patients with autoimmune or neuromuscular conditions?
  3. 3.What is our protocol for treating a severe myasthenia gravis flare or crisis while I am pregnant?
  4. 4.When should we schedule a consultation with an obstetric anesthesiologist to discuss my birth plan and pain management options?
  5. 5.What specific documentation or medical alert information should I provide to the labor and delivery team to ensure magnesium sulfate is never administered?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Obstetric and Neonatal Outcomes in Patients With Maternal Myasthenia Gravis: A Nationwide Cohort Study.

    Lindroos JLV, Bjørk MH, Cohen JM, et al.

    Neurology 2025; (105(8)):e214139 doi:10.1212/WNL.0000000000214139.

    PMID: 41026991
  2. 2

    Myasthenia gravis in pregnancy: Systematic review and case series.

    Banner H, Niles KM, Ryu M, et al.

    Obstetric medicine 2022; (15(2)):108-117 doi:10.1177/1753495X211041899.

    PMID: 35845224
  3. 3

    Systemic Lupus Erythematosus Management in Pregnancy.

    Dao KH, Bermas BL

    International journal of women's health 2022; (14()):199-211 doi:10.2147/IJWH.S282604.

    PMID: 35210867
  4. 4

    The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

    Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al.

    Annals of the rheumatic diseases 2016; (75(5)):795-810 doi:10.1136/annrheumdis-2015-208840.

    PMID: 26888948
  5. 5

    EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update.

    Rüegg L, Pluma A, Hamroun S, et al.

    Annals of the rheumatic diseases 2025; (84(6)):910-926 doi:10.1016/j.ard.2025.02.023.

    PMID: 40287311
  6. 6

    Myasthenia gravis.

    Gilhus NE, Tzartos S, Evoli A, et al.

    Nature reviews. Disease primers 2019; (5(1)):30 doi:10.1038/s41572-019-0079-y.

    PMID: 31048702
  7. 7

    Myasthenia gravis and pregnancy: a systematic review and meta-analysis.

    Miegel L, Hickstein J, Reibelt A, et al.

    Journal of neurology 2026; (273(3)).

    PMID: 41787190
  8. 8

    Myasthenia Gravis in Pregnancy: Prenatal and Postnatal Diagnostic Challenges-A Narrative Review.

    Gerede A, Danavasi M, Oikonomou E, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(6)) doi:10.3390/diagnostics16060899.

    PMID: 41897632
  9. 9

    Nomogram for predicting pregnancy-related relapse of myasthenia gravis.

    Su M, Liu X, Wu Z, et al.

    Orphanet journal of rare diseases 2024; (19(1)):452 doi:10.1186/s13023-024-03466-6.

    PMID: 39617942
  10. 10

    Myasthenia gravis in pregnancy: Experience of a portuguese center.

    Braga AC, Pinto C, Santos E, Braga J

    Muscle & nerve 2016; (54(4)):715-20 doi:10.1002/mus.25095.

    PMID: 26930188
  11. 11

    Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany.

    Draxler J, Meisel A, Stascheit F, et al.

    Archives of gynecology and obstetrics 2024; (310(1)):277-284 doi:10.1007/s00404-024-07436-y.

    PMID: 38492082
  12. 12

    Distinguishing Myasthenia Exacerbation from Severe Preeclampsia: A Diagnostic and Therapeutic Challenge.

    Sikka P, Joshi B, Aggarwal N, et al.

    Journal of clinical and diagnostic research : JCDR 2015; (9(8)):QD05-6 doi:10.7860/JCDR/2015/12789.6357.

    PMID: 26436003
  13. 13

    Severe Preeclampsia in the Setting of Myasthenia Gravis.

    Lake AJ, Al Khabbaz A, Keeney R

    Case reports in obstetrics and gynecology 2017; (2017()):9204930 doi:10.1155/2017/9204930.

    PMID: 28280642
  14. 14

    Transient Neonatal Myasthenia Gravis as a Common Complication of a Rare Disease: A Systematic Review.

    Lindroos JLV, Bjørk MH, Gilhus NE

    Journal of clinical medicine 2024; (13(4)) doi:10.3390/jcm13041136.

    PMID: 38398450
  15. 15

    The expectant management of a rare neonatal disease: transient neonatal myasthenia gravis.

    Masra F, Ishak S, Cheah FC

    The Turkish journal of pediatrics 2023; (65(2)):321-325.

    PMID: 37114697
  16. 16

    Transient Neonatal Myasthenia Gravis: A Case Report.

    Ristovska S, Stomnaroska O, Dimitrioska R

    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2023; (44(2)):165-169 doi:10.2478/prilozi-2023-0036.

    PMID: 37453109
  17. 17

    Transient Neonatal Myasthenia Gravis Born to a Mother with Asymptomatic MG: A Case Report.

    Yang J, Pan L, Liu Y, Wang Y

    Degenerative neurological and neuromuscular disease 2024; (14()):15-19 doi:10.2147/DNND.S451611.

    PMID: 38444566

This page provides educational information about managing myasthenia gravis during pregnancy. Always consult your neurologist and a maternal-fetal medicine specialist before changing your medications or attempting to conceive.

Get notified when new evidence is published on Myasthenia gravis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.